Quality requirements for biocides in the 1990s.
Increasing regulatory and product safety standards along with the enhanced expectations of today's consumer public have dramatically changed the manner in which new biocides are researched, developed, and marketed. Potential candidates face ever rising quality hurdles regarding Product Efficacy, Toxicology, Human Health and Environmental Risk Assessment and Risk Management, and, ultimately, Product Stewardship. These pressures have resulted in long lead times for new products with few companies entering into the biocide market. Another resultant trend has been a strong tendency to expand the life cycles of existing products. This report outlines and summarizes recent activity associated with these quality issues and their relationship to the successful marketing of biocides in the future.
Weiler
E D
ED
Rohm and Haas Company, Product Integrity Department, Philadelphia, Pennsylvania 19105.
Jayjock
M A
MA
Greenley
D E
DE
D002617:Chemical Industry / Q000191:economics / Q000592:standards / Q000706:statistics & numerical data; D003362:Cost-Benefit Analysis; D004338:Drug Combinations; D004353:Drug Evaluation, Preclinical; D006801:Humans; D011358:Product Surveillance, Postmarketing; D011786:Quality Control; D012307:Risk Factors; D012449:Safety
D004338:Drug Combinations